BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Wang Y, Ye X, Liang P. Locoregional Combined With Systemic Therapies for Advanced Hepatocellular Carcinoma: An Inevitable Trend of Rapid Development. Front Mol Biosci 2021;8:635243. [PMID: 33928118 DOI: 10.3389/fmolb.2021.635243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Wu G, Li Q, Zheng Y, Liu M, Zhou L, Chen Z, Wang Y, Guo Q, Ji R, Zhou Y. Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma. Front Mol Biosci 2021;8:690206. [PMID: 34262941 DOI: 10.3389/fmolb.2021.690206] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Tan J, Tang T, Zhao W, Zhang ZS, Xiao YD. Initial Incomplete Thermal Ablation Is Associated With a High Risk of Tumor Progression in Patients With Hepatocellular Carcinoma. Front Oncol 2021;11:760173. [PMID: 34733792 DOI: 10.3389/fonc.2021.760173] [Reference Citation Analysis]
3 Huang L, Xu H, Wu T, Li G. Hedyotis diffusa Willd. Suppresses Hepatocellular Carcinoma via Downregulating AKT/mTOR Pathways. Evid Based Complement Alternat Med 2021;2021:5210152. [PMID: 34527062 DOI: 10.1155/2021/5210152] [Reference Citation Analysis]